Soluble vascular cell adhesion molecule-1 level in patients with anthiphospolipid syndrome: its association with disease activity and endothelium dysfunction

Segeda, Iu.; Shevchuk, S.; Kuvikova, I.

Home
→
НДІ реабілітації інвалідів
→
Наукові публікації НДІ реабілітації інвалідів
→
View Item

dc.contributor.author	Segeda, Iu.	en
dc.contributor.author	Shevchuk, S.	en
dc.contributor.author	Kuvikova, I.	en
dc.date.accessioned	2020-02-11T10:31:55Z
dc.date.available	2020-02-11T10:31:55Z
dc.date.issued	2012
dc.identifier.citation	Segeda Iu. Soluble vascular cell adhesion molecule-1 level in patients with anthiphospolipid syndrome: its association with disease activity and endothelium dysfunction / Iu. Segeda, S. Shevchuk, I. Kuvikova // Rheumatology. – 2012. – Vol. 51, issue suppl. 3, ill.140. – P. 181.	en
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/4346
dc.description.abstract	The aim of this observation case was to investigate the link of soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration with disease activity and endothelium dysfunction as an early marker of atherosclerosis. 67 patients with anthiphospolipid syndrome (APS) were studied: 21 (31.3%) with primary APS (PAPS), 19 (28.4%) with APS associated with systemic lupus erythematosus (APS-SLE), 27 (40.3%) with SLE without APS and 26 age and sex matched healthy controls (HC). According to this data it might be hypothesized that increase sVCAM-1 level is a marker of endothelium dysfunction in patients with APS especially in presence of high disease activity.	en
dc.language.iso	en	en
dc.subject	anthiphospolipid syndrome	en
dc.subject	systemic lupus erythematosus	en
dc.subject	soluble vascular cell adhesion molecule-1	en
dc.subject	endothelium dysfunction	en
dc.subject	atherosclerosis	en
dc.title	Soluble vascular cell adhesion molecule-1 level in patients with anthiphospolipid syndrome: its association with disease activity and endothelium dysfunction	en
dc.type	Thesis	en